Chemistry: analytical and immunological testing – Involving an insoluble carrier for immobilizing immunochemicals
Patent
1995-05-25
1996-08-13
Henley, III, Raymond
Chemistry: analytical and immunological testing
Involving an insoluble carrier for immobilizing immunochemicals
G01N 33543
Patent
active
055455697
ABSTRACT:
TGF-beta activators and TGF-beta production stimulators are employed to maintain or increase vessel lumen diameter in a diseased or injured vessel of a mammal. Conditions such as restenosis following angioplasty, vascular bypass grafts, transplanted organs, atherosclerosis or hypertension are characterized by a reduced vessel lumen diameter. In a preferred embodiment of the invention, TGF-beta activators and production stimulators inhibit abnormal proliferation of smooth muscle cells. TGF-beta activators or production stimulators that are not characterized by an undesirable systemic toxicity profile at a prophylactic dose are also amenable to chronic use for prophylactic purposes with respect to disease states involving proliferation and/or migration of vascular smooth muscle cells over time. Further provided is a method for determining TGF-beta in vitro, thereby identifying a patient at risk for atherosclerosis and monitoring a recipient that has received one or more administrations of a TGF-beta activator or production stimulator.
REFERENCES:
patent: Re32944 (1989-06-01), Harita et al.
patent: 3940422 (1976-02-01), Harita et al.
patent: 4070484 (1978-01-01), Harita et al.
patent: 4235988 (1980-11-01), Fildes et al.
patent: 4442119 (1984-04-01), Magarian et al.
patent: 4512762 (1985-04-01), Spears
patent: 4826672 (1989-05-01), Milius et al.
patent: 4835002 (1989-05-01), Wolf et al.
patent: 4839155 (1989-06-01), McCague
patent: 4859585 (1989-08-01), Sonnenschein et al.
patent: 4879315 (1989-11-01), Magarian et al.
patent: 4929602 (1990-05-01), Harker et al.
patent: 4990538 (1991-02-01), Harris et al.
patent: 4997652 (1991-03-01), Wong
patent: 5015666 (1991-05-01), Magarian et al.
patent: 5026537 (1991-06-01), Dodonna
patent: 5032679 (1991-07-01), Brandley et al.
patent: 5043335 (1991-08-01), Kleinschroth et al.
patent: 5047431 (1991-09-01), Schickaneder et al.
patent: 5049132 (1991-09-01), Shaffer et al.
patent: 5053033 (1991-10-01), Clarke
patent: 5098903 (1992-03-01), Magarian et al.
patent: 5116864 (1992-05-01), March et al.
patent: 5120535 (1992-06-01), Marquardt et al.
patent: 5140012 (1992-08-01), McGovern et al.
patent: 5166143 (1992-11-01), Ondetti et al.
patent: 5180366 (1993-01-01), Woods et al.
patent: 5185260 (1993-02-01), Crissman et al.
patent: 5189046 (1993-02-01), Burch et al.
patent: 5189212 (1993-02-01), Ruenitz
patent: 5192525 (1993-03-01), Yang et al.
patent: 5208019 (1993-05-01), Hansson et al.
patent: 5213576 (1993-05-01), Abiuso et al.
patent: 5213580 (1993-05-01), Slepian et al.
patent: 5216126 (1993-06-01), Cox et al.
patent: 5219548 (1993-06-01), Yang et al.
patent: 5221620 (1993-06-01), Purchio et al.
patent: 5226430 (1993-07-01), Spears et al.
patent: 5229495 (1993-07-01), Ichijo et al.
patent: 5238714 (1993-08-01), Wallace et al.
patent: 5238950 (1993-08-01), Clader et al.
patent: 5248764 (1993-09-01), Flanagan et al.
patent: 5254594 (1993-10-01), Niikura et al.
patent: 5268358 (1993-12-01), Fretto
patent: 5270047 (1993-12-01), Kaufman et al.
patent: 5280016 (1994-01-01), Conrad et al.
patent: 5280109 (1994-01-01), Miyazono et al.
patent: 5283257 (1994-02-01), Gregory et al.
patent: 5284763 (1994-02-01), Derynk et al.
patent: 5284869 (1994-02-01), Bisaccia et al.
patent: 5288711 (1994-02-01), Mitchell et al.
patent: 5296492 (1994-03-01), Shiozawa et al.
patent: 5304325 (1994-04-01), Kaufman et al.
patent: 5304541 (1994-04-01), Purchio et al.
patent: 5308622 (1994-05-01), Casscells et al.
patent: 5308862 (1994-05-01), Ohlstein
patent: 5316766 (1994-05-01), Baldus et al.
patent: 5324736 (1994-06-01), Magarian et al.
patent: 5326757 (1994-07-01), Demopoulos
patent: 5340925 (1994-08-01), Lioubin et al.
patent: 5346993 (1994-09-01), Miyazono et al.
patent: 5354562 (1994-10-01), Platz et al.
patent: 5354774 (1994-10-01), Deckelbaum et al.
patent: 5354801 (1994-10-01), O'Toole et al.
patent: 5362424 (1994-11-01), Lee et al.
patent: 5364632 (1994-11-01), Benita et al.
patent: 5380716 (1995-01-01), Conrad et al.
patent: 5384332 (1995-01-01), Fontana
patent: 5385935 (1995-01-01), Tamai et al.
patent: 5389670 (1995-02-01), Fontana
patent: 5391557 (1995-02-01), Cullinan et al.
patent: 5393763 (1995-02-01), Black et al.
patent: 5393772 (1995-02-01), Yue et al.
patent: 5441947 (1995-08-01), Dodge et al.
patent: 5444164 (1995-08-01), Purchio et al.
Anderson et al., "Effects of Acetate Dialysate on Transforming Growth Factor .beta..sub.1 -interleukin and .beta..sub.2 -microglobulin Plasma Levels," Kidney International, 40, 1110-1117 (Oct. 1991).
Assoian et al., "Type .beta. Transforming Growth Factor in Human Platelets: Release During Platelet Degranulation and Action on Vascular Smooth Muscle Cells," J. Cell. Biol., 102, 1217-1223 (Apr. 1986).
Attwood et al., "A Light Scattering Study on Oil-in-Water Microemulsions", Int'l J. Pharm., 52, 165-171 (1989).
Bagdade et al., "Effects of Tamoxifen Treatment on Plasma Lipids and Lipoprotein Lipid Composition," J. Clinical Endocrinology and Metabolism, 70, 1132-1135 (1990).
Benita et al., "Submicron Emulsions as Colloidal Drug Carriers for Intravenous Administration: Comprehensive Physicochemical Characterization," J. of Pharmaceutical Sciences, 82, 1069-1079 (Nov. 1993).
Bertelli et al., "Adjuvant Tamoxifen in Primary Breast Cancer: Influence on Plasma Lipids and Antithrombin III Levels," Breast Cancer Res. and Treatment, 12, 307-310 (1988).
Bier et al., "Arterial Remodeling: Importance in Primary Versus Restenoic Lesions," JACC, p. 139A, Abstract No. 875-96 (1994).
Bluming, "Hormone Replacement Therapy: Benefits and Risks for the General Postmenopausal Female Population and for Women with a History of Previously Treated Breast Cancer," Seminars in Oncology, 20, 662-674 (Dec. 1993).
Brott et al., "Vessel Remodeling After Angioplasty: Comparative Anatomic Studies," JACC, p. 138A, Abstract No. 875-43 (1994).
Bruengger et al., "Smooth Muscle Cell of the Canine Prostate in Spontaneous Benign Hyperplasia, Steroid Induced Hyperplasia and Estrogen or Tamoxifen Treated Dogs," J. Urology, 130, 1208-1210 (Dec. 1983).
Bruning et al., "Tamoxifen, Serum Lipoproteins and Cardiovascular Risk," Br. J. Cancer, 58, 497-499 (1988).
Chander et al., "Pyrrolidino-4-iodotamoxifen and 4-iodotamoxifen, New Analogues of the Antiestrogen Tamoxifen for the Treatment of Breast Cancer," Cancer Res., 51, 5851-5858 (Nov. 1, 1991).
Chao et al., "Altered Cytokine Release in Peripheral Blood Mononuclear Cell Cultures from Patients with the Chronic Fatigue Syndrome," Cytokine, 3, 292-298 (Jul. 1991).
Charlier et al., "Tamoxifen in the Treatment of Breast Cancer," J. Gynecol. Obstet. Biol. Reprod. (Paris), 23, 751-756 (1994).
Clowes et al., "Kinetics of Cellular Proliferation after Arterial Injury--I. Smooth Muscle Growth in the Absence of Endothelium", Laboratory Investigation, 49, 327-333 (1983).
Clowes et al., "Kinetics of Cellular Proliferation after Arterial Injury--III. Endothelium and Smooth Muscle Growth in Chronically Denuded Vessels", Laboratory Investigation, 54, 295-303 (1986).
Clowes et al., "Mechanisms of Stenosis after Arterial Injury", Laboratory Investigation, 49, 208-215 (1983).
Clowes et al., "Significance of Quiescent Smooth Muscle Migration in the Injured Rat Carotid Artery", Cir. Res., 56, 139-145 (Jan. 1985).
Cotton, "Restenosis Trials Suggest Role for Remodeling, Medical News and Perspective," JAMA, 271, 1302-1305 (1994).
Craig et al., "Anticoagulant Drugs", Modern Pharmacology, p. 399, Little, Brown and Company (1982).
Crissman et al., "Transformed Mammalian Cells are Deficient in Kinase-Mediated Control of Progression Through the GI Phase of the Cell Cycle," PNAS USA, 88, 7580-7584 (Sep. 1991).
Danielpour et al., "Evidence for Differential Regulation of TGF-.beta..sub.1 and TGF-.beta..sub.2 Expression in Vivo by Sandwich Enzyme-linked Immunosorbent Assays," Annals N.Y. Acad. Sci., 593, 300-302 (1990).
Danielpour et al., "Immunodetection and Quantitation of the Two Forms of Transforming Growth Factor-Beta (TGF-.beta.1 and TGF-.beta.2) Secreted by Cells in Culture," J. Cell Physiol., 138, 79-86 (1989).
Danielpour, "Improved Sandwich
Grainger David J.
Metcalfe James C.
Weissberg Peter L.
Henley III Raymond
NeoRx Corporation
LandOfFree
Prevention and treatment of pathologies associated with abnormal does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Prevention and treatment of pathologies associated with abnormal, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Prevention and treatment of pathologies associated with abnormal will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-1047597